Cuorips Inc. (JP:4894)

:4894

4894

Cuorips Inc.

RESEARCH TOOLSreports

Cuorips Inc. (4894) Price & Analysis

Compare

1 Followers

4894 Stock Chart & Stats

¥6230.00

¥25.00(0.51%)

At close: Jan 08 4:00 PM EST

¥6230.00

¥25.00(0.51%)

Day’s Range― - ―

52-Week Range¥5,580.00 - ¥12,400.00

Previous CloseN/A

Volume173.60K

Average Volume (3M)107.56K

Market Cap

¥58.63B

Enterprise Value¥54.74B

Total Cash (Recent Filing)¥4.85B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)―

Beta1.11

Next Earnings

May 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-30.15

Shares Outstanding8,273,376

10 Day Avg. Volume98,200

30 Day Avg. Volume107,556

Financial Highlights & Ratios

PEG Ratio16.56

Price to Book (P/B)12.03

Price to Sales (P/S)379.55

P/FCF Ratio-74.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetA debt-free capital structure with equity materially covering assets reduces refinancing and interest-rate risk, giving management flexibility to fund R&D and operations from the balance sheet. This structural strength lengthens runway and supports strategic choices without immediate borrowing.

Strong Recent Revenue AccelerationA ~404% YoY revenue jump indicates improving commercial traction and product adoption versus the prior base. Sustained high top-line growth provides a pathway to scale fixed-cost absorption and eventual margin recovery if sales growth persists and commercialization execution continues.

Diversified Commercialization Revenue ModelMultiple revenue streams—product sales, institutional partnerships, licensing and grants—provide structural resilience by reducing dependence on a single channel. This diversity helps fund development, offers partnership optionality, and can stabilize cash inflows as commercialization expands.

Bears Say

High And Persistent Cash BurnSubstantially negative operating and free cash flows represent a recurring structural drain on resources. Over multiple quarters this necessitates external financing or asset sales, limits reinvestment flexibility, and increases the company's vulnerability to funding shocks if revenue growth slows.

Large Operating Losses And Negative MarginsMaterial operating losses and deeply negative margins show the cost base remains well ahead of revenue. Without durable margin improvement—either via higher volumes, pricing power, or structural cost reductions—the firm risks prolonged capital consumption and delayed path to profitability.

Elevated Dilution / Financing RiskGiven limited internal cash generation and no debt drawdown, the company is structurally exposed to equity raises or continued reliance on grants/partners. Recurrent capital raises would dilute shareholders, potentially constrain long-term returns and influence strategic priorities toward near-term financing.

4894 FAQ

What was Cuorips Inc.’s price range in the past 12 months?

Cuorips Inc. lowest stock price was ¥5580.00 and its highest was ¥12400.00 in the past 12 months.

What is Cuorips Inc.’s market cap?

Cuorips Inc.’s market cap is ¥58.63B.

When is Cuorips Inc.’s upcoming earnings report date?

Cuorips Inc.’s upcoming earnings report date is May 20, 2026 which is in 53 days.

How were Cuorips Inc.’s earnings last quarter?

Cuorips Inc. released its earnings results on Feb 18, 2026. The company reported -¥30.15 earnings per share for the quarter, missing the consensus estimate of N/A by -¥30.15.

Is Cuorips Inc. overvalued?

According to Wall Street analysts Cuorips Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cuorips Inc. pay dividends?

Cuorips Inc. does not currently pay dividends.

What is Cuorips Inc.’s EPS estimate?

Cuorips Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cuorips Inc. have?

Cuorips Inc. has 8,273,376 shares outstanding.

What happened to Cuorips Inc.’s price movement after its last earnings report?

Cuorips Inc. reported an EPS of -¥30.15 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.324%.

Which hedge fund is a major shareholder of Cuorips Inc.?

Currently, no hedge funds are holding shares in JP:4894

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cuorips Inc.

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.